Ken Livak

Ken Livak, a Lead Scientist at Dana-Farber Cancer Institute, has a strong background in genomics and molecular biology. With experience at Fluidigm Corporation and Applied Biosystems, Ken has been involved in various initiatives focused on technology development and single cell genomics. Ken holds a Ph.D. in Biochemistry & Molecular Biology from Harvard University and a Bachelor of Science in Chemistry from Harvey Mudd College.